SAN DIEGO, Dec. 8 /PRNewswire/ -- Three of the world’s top research scientists will participate in a freewheeling conversation on RNA interference (RNAi), tissue regeneration, and noncoding DNA on BioTech Today from 1PM to 2PM, PST, on Wednesday, December 10 at http://www.biotechtoday.net/ . The three panelists are Dr. Andrew Fire, Dr. Alejandro Sanchez Alvarado, and Dr. John Mattick. Dr. Fire is the co-discoverer of RNAi and is a faculty member at Stanford University’s School of Medicine, Dr. Sanchez is Associate Professor, Department of Neurobiology and Anatomy, University of Utah School of Medicine, and Dr. Mattick is the Foundation Professor of Molecular Biology and the Director of the Institute for Molecular Bioscience at the University of Queensland, Australia.
“All three of our panelists are engaged in critical research that will have a major influence on the design and actions of next generation medicines and biotechnologies,” said Sam Kephart, Executive Producer of BioTech Today.
BioTech Today is a weekly talk radio show, streamed live via the web, focusing on biotechnology, nanotechnology, pharma, and biomedicine. Its mission is to create an industry forum to promote the success of the biotechnology and nanotechnology industries. The promise of biotech and nanotech impacts directly on our wellbeing, now and in the future, and is of vastly greater significance than the daily stock price fluctuations or even quarterly financial reports of the companies involved. By providing a supportive conversational environment for entrepreneurs, CEO’s, researchers, venture capitalists, and intellectual property attorneys, BioTech Today participates in the process of strengthening the biotech and nanotech industries, with beneficial effects on the industries, their sources of financial support, and the public at large.
BioTech Today is co-hosted by Dr. David Lemberg and Sam Kephart, who bring their combined skill set of biotech smarts and business savvy to the studio microphone.
Dr. David Lemberg (619-540-9038; davidlemberg@earthlink.net ) is a biotechnology communications consultant with a formal background in biochemistry research.
Sam Kephart (619-889-8558; sam2sam@aol.com ) is President and CEO of Virtual Acumen, a digital media developer, specializing in medical e-learning, based in San Diego.
Virtual Acumen
CONTACT: Dr. David Lemberg, +1-619-540-9038, or fax, +1-858-793-0366,davidlemberg@earthlink.net; or Sam Kephart of President and CEO of VirtualAcumen, +1-619-889-8558, sam2sam@aol.com
Web site: http://www.biotechtoday.net/
